HemLibra Prophylaxis in Patients With Hemophilic Pseudotumor
Condition: Haemophilic Pseudotumour Intervention: Drug: Emicizumab Sponsors: Indiana Hemophilia &Thrombosis Center, Inc.; Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials